Mylan Inventory Turnover Ratio 2006-2018 | MYL

Current and historical inventory turnover ratio for Mylan (MYL) from 2006 to 2018. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period. Mylan inventory turnover ratio for the three months ending September 30, 2018 was 0.71.
Mylan Inventory Turnover Ratio Historical Data
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $16.552B $11.908B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $45.888B 8.26
Teva Pharmaceutical Industries (TEVA) Israel $18.324B 6.32
Bausch Health Cos (BHC) Canada $8.810B 6.38
Dr Reddy's Laboratories (RDY) India $6.044B 24.11
Supernus Pharmaceuticals (SUPN) United States $1.990B 18.86
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.827B 3.05
Amphastar Pharmaceuticals (AMPH) United States $1.121B 121.55
Homology Medicines (FIXX) United States $0.901B 0.00
CymaBay Therapeutics (CBAY) United States $0.612B 0.00
Assembly Biosciences (ASMB) United States $0.573B 0.00
Akorn (AKRX) United States $0.558B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.402B 0.00
Voyager Therapeutics (VYGR) United States $0.351B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.292B 0.00
Sol-Gel Technologies (SLGL) Israel $0.123B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.089B 0.00
Teligent (TLGT) United States $0.087B 0.00
Acasti Pharma (ACST) Canada $0.072B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.062B 0.00
Evoke Pharma (EVOK) United States $0.056B 0.00
Agile Therapeutics (AGRX) United States $0.035B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
China Pharma Holdings (CPHI) China $0.012B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.005B 0.00